Junevity

Junevity is a biotechnology company developing cellular reset therapies for longevity. The Junevity RESET platform pioneers the use of large-scale human data and AI to identify transcription factor targets and employs siRNA therapies to inhibit them. The company is advancing siRNA therapies to address diseases that collectively impact billions of people worldwide, including type 2 diabetes, obesity, and frailty.